abstract |
The present invention is directed to the use of a composition comprisingn a) N-(5-chlorosalicyloyl)-8-aminocaprylic acid, wherein N-(5-chlorosalicyloyl)-8-aminocaprylicnacid comprises at least about 96% by weight of the disodiumnsalt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid; and b) salmon calcitonin, for the preparation of a medicament for orallynadministering salmon calcitonin to an animal. |